-
CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED - C/O The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, CB22 3FH, United Kingdom
Company Information
- Company registration number
- 09686738
- Company Status
- LIVE
- Country
- United Kingdom
- Registered Address
- C/O The Cambridge Partnership Ltd, The Dorothy Hodgkin Building
- Babraham Research Campus, Babraham
- Cambridge
- CB22 3FH
- United Kingdom C/O The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, CB22 3FH, United Kingdom UK
Management
- Managing Directors
- HUSSAIN, Iqbal
- SAHA, Saurabh, Dr
- THORELL, Marella
- Company secretaries
- THE CAMBRIDGE PARTNERSHIP LIMITED
Company Details
- Type of Business
- ltd
- Incorporated
- 2015-07-15
- Age Of Company 2015-07-15 8 years
- SIC/NACE
- 72110
Ownership
- Beneficial Owners
- United Medicines Biopharma Limited
Jurisdiction Particularities
- Additional Status Details
- active
- Filing of Accounts
- Due Date: 2022-09-30
- Last Date: 2020-12-31
- Annual Return
- Due Date: 2022-07-28
- Last Date: 2021-07-14
-
CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Company Description
- CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED is a ltd registered in United Kingdom with the Company reg no 09686738. Its current trading status is "live". It was registered 2015-07-15. It has declared SIC or NACE codes as "72110". It has 3 directors and 1 secretary. The latest accounts are filed up to 2019-07-31.It can be contacted at C/o The Cambridge Partnership Ltd, The Dorothy Hodgkin Building .
Get CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Register ReportAnnual AccountsShareholder ListArticles of AssociationBeneficial Owners Check
You are here: Centessa Pharmaceuticals (Morphogen-Ix) Limited - C/O The Cambridge Partnership Ltd, The Dorothy Hodgkin Building, Babraham Research Campus, Babraham, Cambridge, CB22 3FH, United Kingdom
- 2015-07-15
- 0-2
- 3-5
- 6-20
- 21-50
- 51+
- years
Did you know? kompany provides original and official company documents for CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED as filed with the government register. Guaranteed.
Register Report
Official proof of the company existence
Annual Accounts
Financial data for the last reported full year
Shareholder List
Details on the shareholders
Articles of Association
Founding documents
Beneficial Owners Check
Beneficial Owners details
Official Filings
Company filings direct from the official registry.
keyboard_arrow_down 2021
-
change-account-reference-date-company-previous-extended (2021-04-15) - AA01
-
termination-director-company-with-name-termination-date (2021-02-10) - TM01
-
appoint-person-director-company-with-name-date (2021-02-10) - AP01
-
resolution (2021-01-14) - RESOLUTIONS
-
capital-cancellation-shares (2021-01-14) - SH06
-
withdrawal-of-a-person-with-significant-control-statement (2021-02-11) - PSC09
-
notification-of-a-person-with-significant-control (2021-02-11) - PSC02
-
resolution (2021-02-23) - RESOLUTIONS
-
memorandum-articles (2021-02-23) - MA
-
resolution (2021-10-24) - RESOLUTIONS
-
mortgage-create-with-deed-with-charge-number-charge-creation-date (2021-10-21) - MR01
-
mortgage-create-with-deed-with-charge-number-charge-creation-date (2021-10-19) - MR01
-
mortgage-create-with-deed-with-charge-number-charge-creation-date (2021-10-15) - MR01
-
accounts-with-accounts-type-total-exemption-full (2021-09-30) - AA
-
confirmation-statement-with-updates (2021-08-11) - CS01
-
capital-return-purchase-own-shares (2021-02-12) - SH03
keyboard_arrow_right 2020
-
accounts-with-accounts-type-small (2020-04-21) - AA
-
confirmation-statement-with-no-updates (2020-07-15) - CS01
-
change-registered-office-address-company-with-date-old-address-new-address (2020-08-27) - AD01
-
change-registered-office-address-company-with-date-old-address-new-address (2020-10-02) - AD01
keyboard_arrow_right 2019
-
accounts-with-accounts-type-total-exemption-full (2019-04-26) - AA
-
capital-allotment-shares (2019-01-15) - SH01
-
resolution (2019-01-08) - RESOLUTIONS
-
confirmation-statement-with-updates (2019-07-15) - CS01
-
capital-allotment-shares (2019-04-25) - SH01
keyboard_arrow_right 2018
-
capital-allotment-shares (2018-12-18) - SH01
-
second-filing-capital-allotment-shares (2018-09-20) - RP04SH01
-
capital-allotment-shares (2018-08-21) - SH01
-
confirmation-statement-with-no-updates (2018-07-24) - CS01
-
accounts-with-accounts-type-total-exemption-full (2018-04-23) - AA
keyboard_arrow_right 2017
-
resolution (2017-09-22) - RESOLUTIONS
-
termination-director-company-with-name-termination-date (2017-05-22) - TM01
-
appoint-person-director-company-with-name-date (2017-05-22) - AP01
-
accounts-with-accounts-type-total-exemption-small (2017-04-12) - AA
-
second-filing-capital-allotment-shares (2017-04-28) - RP04SH01
-
confirmation-statement-with-updates (2017-07-25) - CS01
keyboard_arrow_right 2016
-
capital-name-of-class-of-shares (2016-12-20) - SH08
-
change-person-director-company-with-change-date (2016-09-23) - CH01
-
confirmation-statement-with-updates (2016-07-18) - CS01
-
change-registered-office-address-company-with-date-old-address-new-address (2016-01-25) - AD01
-
appoint-person-director-company-with-name-date (2016-01-20) - AP01
-
capital-allotment-shares (2016-01-18) - SH01
keyboard_arrow_right 2015
-
resolution (2015-11-24) - RESOLUTIONS
-
incorporation-company (2015-07-15) - NEWINC
-
capital-name-of-class-of-shares (2015-11-24) - SH08
-
appoint-person-director-company-with-name-date (2015-11-28) - AP01
-
capital-allotment-shares (2015-11-24) - SH01
-
appoint-person-director-company-with-name-date (2015-11-26) - AP01